Perrigo Company plc (PRGO)
NYSE: PRGO · IEX Real-Time Price · USD
27.48
-0.36 (-1.29%)
At close: Jul 12, 2024, 4:00 PM
27.45
-0.03 (-0.11%)
After-hours: Jul 12, 2024, 7:43 PM EDT

Company Description

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally.

It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products.

The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands.

It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies.

The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013.

Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Perrigo Company plc
Perrigo Company logo
Country Ireland
Founded 1887
IPO Date Dec 16, 1991
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 9,140
CEO Patrick Lockwood-Taylor

Contact Details

Address:
The Sharp Building, Hogan Place
Dublin 2, L2 D02 TY74
Ireland
Phone 269-673-8451
Website perrigo.com

Stock Details

Ticker Symbol PRGO
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001585364
CUSIP Number G97822103
ISIN Number IE00BGH1M568
SIC Code 2834

Key Executives

Name Position
Patrick Lockwood-Taylor President, Chief Executive Officer and Director
Eduardo Guarita Bezerra Executive Vice President and Chief Financial Officer
Ronald C. Janish Chief Transformation Officer and Executive Vice President of Global Operations and Supply Chain
Kyle L. Hanson Executive Vice President, General Counsel and Corporate Secretary
Svend Andersen Executive Vice President and President of Consumer Self-Care International
Shannon Hukill Senior Director of Technical Operations
Thomas M. Farrington Chief Information Officer and Executive Vice President
Alison Ives Executive Vice President and Chief Scientific Officer
Bradley Joseph Vice President of Global Investor Relations and Corporate Communications
Mary Reilly-Brest Director of Global Organizational and Human Resource Development

Latest SEC Filings

Date Type Title
Jul 10, 2024 8-K Current Report
Jun 25, 2024 11-K Annual report of employee stock purchase, savings and similar plans
Jun 11, 2024 144 Filing
Jun 10, 2024 8-K Current Report
May 28, 2024 8-K Current Report
May 17, 2024 144 Filing
May 15, 2024 SD Form - SD
May 10, 2024 144 Filing
May 7, 2024 10-Q Quarterly Report
May 7, 2024 8-K Current Report